Xencor Inc (XNCR) Stock Price Today & Analysis
XNCR
Valuation
Market cap$913.34M
Price-to-sales ratio6.28
Price-to-book value1.51
Price-earnings ratio-7.20
Return on Equity-20.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.73
Income Statement
Average volume818,145
EBITDA$-84.93M
1 year high (52w)$21.00
1 year low (52w)$6.92
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About Xencor Inc
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
FAQ
You can easily purchase Xencor Inc (XNCR) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'XNCR' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Xencor Inc with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
